Home > Authorities > Institutes > Record #113962 |
L101
DKTK HeidelbergID | I:(DE-He78)L101-20160331 |
⇧ Deutsches Krebsforschungszentrum ⇧
All known publications ...
Download: BibTeX | EndNote XML, Text | RIS |
Journal Article
Cancer Neoepitopes for Immunotherapy: Discordance Between Tumor-Infiltrating T Cell Reactivity and Tumor MHC Peptidome Display.
Frontiers in immunology 10, 2766 (2019) [10.3389/fimmu.2019.02766]
Fulltext by Pubmed Central
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article (Erratum/Correction)
Publisher Correction: Absence of NKG2D ligands defines leukaemia stem cells and mediates their immune evasion.
Nature <London> 572(7770), E19 - E19 (2019) [10.1038/s41586-019-1475-x]
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article (Erratum/Correction)
Publisher Correction: Shared heritability and functional enrichment across six solid cancers.
Nature Communications 10(1), 4386 (2019) [10.1038/s41467-019-12095-8]
Fulltext by Pubmed Central
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
Dose-Limiting Organs at Risk in Carbon Ion Re-Irradiation of Head and Neck Malignancies: An Individual Risk-Benefit Tradeoff.
Cancers 11(12), 2016 (2019) [10.3390/cancers11122016]
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
Temporal muscle thickness is an independent prognostic marker in patients with progressive glioblastoma: translational imaging analysis of the EORTC 26101 trial.
Neuro-Oncology 21(12), 1587 - 1594 (2019) [10.1093/neuonc/noz131]
Fulltext by Pubmed Central
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article (Review Article)
Optimizing Manufacturing Protocols of Chimeric Antigen Receptor T Cells for Improved Anticancer Immunotherapy
International journal of molecular sciences 20(24), e6223 (2019) [10.3390/ijms20246223]
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
JAK/STAT-Activating Genomic Alterations Are a Hallmark of T-PLL
Cancers 11(12), e1833 (2019) [10.3390/cancers11121833]
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
Comparison of different semi-automated cfDNA extraction methods in combination with UMI-based targeted sequencing
OncoTarget 10(55), 5690-5702 (2019) [10.18632/oncotarget.27183]
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article (Review Article)
A Phase I/II first-line study of R-CHOP plus B-cell receptor/NF-κB-double-targeting to molecularly assess therapy response.
International Journal of Hematologic Oncology 8(4), IJH20 (2019) [10.2217/ijh-2019-0010]
Fulltext by Pubmed Central
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
Personalized Radiotherapy Design for Glioblastoma: Integrating Mathematical Tumor Models, Multimodal Scans, and Bayesian Inference
IEEE transactions on medical imaging 38(8), 1875 - 1884 (2019) [10.1109/TMI.2019.2902044]
BibTeX |
EndNote:
XML,
Text |
RIS
All known publications ...
Download: BibTeX | EndNote XML, Text | RIS |